The biotechnology industry presents a high-stakes investment landscape, where outcomes for investors are often binary and the line between success and failure is remarkably thin. In the best-case ...

Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. When it comes to biotech ETFs, they give sector participants exposure to many biotech companies via one ...